Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) Tax Provisions (2016 - 2024)

Trinity Biotech's Tax Provisions history spans 16 years, with the latest figure at $3000.0 for Q2 2024.

  • On a quarterly basis, Tax Provisions rose 101.04% to $3000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was -$401000.0, a 50.19% decrease, with the full-year FY2025 number at $199000.0, down 59.05% from a year prior.
  • Tax Provisions hit $3000.0 in Q2 2024 for Trinity Biotech, up from -$67000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for TRIB hit a ceiling of $937000.0 in Q4 2021 and a floor of -$655000.0 in Q2 2021.
  • Historically, Tax Provisions has averaged -$85062.5 across 5 years, with a median of -$88000.0 in 2020.
  • Biggest five-year swings in Tax Provisions: skyrocketed 1419.72% in 2021 and later tumbled 11000.0% in 2023.
  • Tracing TRIB's Tax Provisions over 5 years: stood at -$71000.0 in 2020, then skyrocketed by 1419.72% to $937000.0 in 2021, then tumbled by 98.61% to $13000.0 in 2022, then plummeted by 984.62% to -$115000.0 in 2023, then surged by 102.61% to $3000.0 in 2024.
  • Business Quant data shows Tax Provisions for TRIB at $3000.0 in Q2 2024, -$67000.0 in Q1 2024, and -$115000.0 in Q4 2023.